Ark Therapeutics Group PLC Signed Heads of Terms and Suspension of Trading (4238D)

TIDMAKT

RNS Number : 4238D

Ark Therapeutics Group PLC

28 March 2014

28 March 2014

Ark Therapeutics Group plc

("Ark" or the "Company")

Signed Heads of Terms and Suspension of Trading

The Board of Ark is pleased to announce that the Company has signed heads of terms in connection with the possible acquisition of a revenue-generating and profitable UK-based private company in the healthcare support services sector ("Target").

The transaction would be structured by way of an acquisition of the Target by Ark in consideration for the issue of new Ark shares to the shareholders of the Target. Due to its size in relation to Ark, the proposed acquisition of the Target constitutes a "reverse takeover" for the purposes of the Listing Rules. However the intention would be that the existing Ark shareholders would retain a significant minority of the equity of the enlarged Company. The Company has requested that the listing of Ark's Premium listed shares on the Main Market of the London Stock Exchange be suspended by the UK Listing Authority pending publication of the required shareholder documents. Shareholder approval would be required to approve the acquisition of the Target which would be sought at a general meeting to be convened in due course, after which the Company also expects to seek a lifting of the trading suspension.

The Board expects to make a further announcement in due course.

For further information please contact:

 
 Ark Therapeutics Group plc            Tel: [phone] 
 Iain G Ross, Non-Executive Chairman 
 David Venables, Non-Executive 
  Director 
 

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding Ark's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Ark's control that could cause the actual results, performance or achievements of Ark to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Ark's present and future business strategies and the environment in which Ark will operate in the future. These forward-looking statements speak only as at the date of this announcement. Ark expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Ark's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFMGZFNRGGDZG